Regulatory Data Growth Aqtual emphasizes data integrity and GxP systems through recent leadership hires, signaling a need for scalable, compliant data management, ELN/LIMS, and audit-ready infrastructure to support its translational research and clinical programs.

Clinical Trial Enablement With the PRIMA-102 RA proof-of-concept study and ongoing translational work, there is a clear opportunity to offer end-to-end clinical trial software, EDC/IMS, biomarker data integration, patient recruitment support, and CRO partnerships to accelerate study timelines.

Growth Funding Leverage The Series B funding signals budget and appetite for external partnerships to scale platform operations; target conversations around cloud infrastructure, data security, validation services, and scalable analytics to meet expanding research and regulatory demands.

Leadership Expansion Key hires across Translational Research, Scientific & Medical Affairs, and Data Integrity/GxP indicate priorities in scientific rigor and strategic collaborations; position partnerships that reinforce translational capabilities, data governance, and regulatory-compliant collaboration tools.

Tech Stack Fit The tech footprint including Node.js, Lua, and OpenResty alongside a web-based platform suggests opportunities to provide integrated software development, API-first solutions, data pipelines, and secure cloud hosting with compliance features for the cfDNA platform and partner integrations.